rs376833288
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The ENST00000567169.5(ZNF423):c.-5C>T variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.0000235 in 1,614,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000567169.5 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Publications
- nephronophthisis 14Inheritance: AD, Unknown, AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- Joubert syndrome with oculorenal defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nephronophthisis 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nephronophthisisInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000567169.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ZNF423 | NM_001379286.1 | MANE Select | c.371C>T | p.Thr124Met | missense | Exon 4 of 8 | NP_001366215.1 | ||
| ZNF423 | NM_001330533.2 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain | Exon 2 of 6 | NP_001317462.1 | ||||
| ZNF423 | NM_015069.5 | c.347C>T | p.Thr116Met | missense | Exon 4 of 8 | NP_055884.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ZNF423 | ENST00000567169.5 | TSL:1 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain | Exon 2 of 6 | ENSP00000455061.1 | |||
| ZNF423 | ENST00000563137.7 | TSL:5 MANE Select | c.371C>T | p.Thr124Met | missense | Exon 4 of 8 | ENSP00000455588.3 | ||
| ZNF423 | ENST00000562520.1 | TSL:1 | c.167C>T | p.Thr56Met | missense | Exon 4 of 8 | ENSP00000457664.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152202Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251098 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461764Hom.: 0 Cov.: 35 AF XY: 0.0000316 AC XY: 23AN XY: 727176 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152320Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74478 show subpopulations
ClinVar
Submissions by phenotype
Nephronophthisis 14 Uncertain:1
This sequence change replaces threonine with methionine at codon 116 of the ZNF423 protein (p.Thr116Met). The threonine residue is moderately conserved and there is a moderate physicochemical difference between threonine and methionine. This variant is present in population databases (rs376833288, ExAC 0.01%). This variant has not been reported in the literature in individuals with ZNF423-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at